Functional and molecular characterization of PD1(+) tumor-infiltrating lymphocytes from lung cancer patients

Antibody-mediated cancer immunotherapy targets inhibitory surface molecules, such as PD1, PD-L1, and CTLA-4, aiming to re-invigorate dysfunctional T cells. We purified and characterized tumor-infiltrating lymphocytes (TILs) and their patient-matched non-tumor counterparts from treatment-naïve NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales: Lipp, Jesse J., Wang, Limei, Yang, Haitang, Yao, Feng, Harrer, Nathalie, Müller, Stefan, Berezowska, Sabina, Dorn, Patrick, Marti, Thomas M., Schmid, Ralph A., Hegedüs, Belazs, Souabni, Abdallah, Carotta, Sebastian, Pearson, Mark A., Sommergruber, Wolfgang, Kocher, Greg J., Hall, Sean R.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837234/
https://www.ncbi.nlm.nih.gov/pubmed/35154905
http://dx.doi.org/10.1080/2162402X.2021.2019466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837234/
https://www.ncbi.nlm.nih.gov/pubmed/35154905
http://dx.doi.org/10.1080/2162402X.2021.2019466

Ejemplares similares